Conclusion: Patients with metastatic RCC, less than three metastatic locations and a Karnofsky score >70% can be considered for HSCT. Posttransplant DLI and ...
Patients with metastatic RCC, less than three metastatic locations and a Karnofsky score >70% can be considered for HSCT. Posttransplant DLI and limited ...
We evaluated the experience of allogeneic HSCT for renal cell carcinoma (RCC) in Europe. Methods and Patients: We report the data on 124 patients with clear ...
Missing: haematopoietic | Show results with:haematopoietic
Background: An allogeneic antitumour effect has been reported for various cancers. We evaluated the experience of allogeneic haematopoietic stem cell ...
Allogeneic hematopoietic stem cell transplantation from a compatible donor has been utilized as adoptive immunotherapy in metastatic, cytokine‐refractory renal ...
Missing: Europe | Show results with:Europe
People also ask
What is the survival rate for hematopoietic stem cell transplant?
Annual relative survival for survivors of allogeneic HCT was 96% to 99% of the general population but only 89% to 96% of the general population for recipients of autologous HCT.
How much does a hematopoietic stem cell transplant cost?
The median outpatient costs and pharmacy costs were similar between the allogeneic NMA cohort ($41,349 and $6551, respectively) and the allogeneic MA cohort ($40,655 and $6451); these costs were higher than the costs for the autologous MA cohort ($18,400 and $673; Table 2).
What is the difference between allogeneic and hematopoietic stem cell transplantation?
Hematopoietic stem cells obtained from an identical twin are referred to as syngeneic obtained, and hematopoietic stem cells from someone other than the patient or an identical twin are referred to as allogeneic, which is the focus of this chapter.
What is haematopoietic stem cell transplantation in haematological malignancies?
For this type of transplant, HSC derived from the donor is infused in the patient after high-dose chemotherapy with or without radiotherapy. Allogenic HSCT is commonly used as consolidation therapy for acute leukemia, relapsed lymphomas, and myelodysplastic syndromes (Sharma et al., 2021).
Nov 15, 2006 · Another immunotherapy approach being studied for the treatment of metastatic RCC is allogeneic hematopoietic stem cell transplantation as a ...
Background: An allogeneic antitumour effect has been reported for various cancers. We evaluated the experience of allogeneic haematopoietic stem cell ...
Allogeneic stem-cell transplantation remains a research-based approach for patients who have not responded to conventional treatments for metastatic RCC. GVHD ...
Nov 1, 2004 · The management of metastatic renal cell carcinoma (mRCC) remains a therapeutic challenge; less than 10% of patients survive for longer than 5 years.
Missing: haematopoietic | Show results with:haematopoietic
Dec 7, 2004 · Conclusions: Treatment of metastatic renal cell carcinoma with allogeneic hematopoietic cell transplantation after nonmyeloablative conditioning ...